ArticleCancer chemotherapy and pharmacology2011

A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumors.

George R Simon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.